β-Amyloid 22-35
CAS No. 144189-71-9
β-Amyloid 22-35( Amyloid β-Protein (22-35) )
Catalog No. M29924 CAS No. 144189-71-9
β-Amyloid (22-35) is a 14-aa peptide, shows aggregates and induces neurotoxicity in the hippocampal cells. Beta amyloid (22-35) is a synthetic truncated fragment of beta-amyloid peptide.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 206 | Get Quote |
|
| 10MG | 356 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Nameβ-Amyloid 22-35
-
NoteResearch use only, not for human use.
-
Brief Descriptionβ-Amyloid (22-35) is a 14-aa peptide, shows aggregates and induces neurotoxicity in the hippocampal cells. Beta amyloid (22-35) is a synthetic truncated fragment of beta-amyloid peptide.
-
Descriptionβ-Amyloid (22-35) is a 14-aa peptide, shows aggregates and induces neurotoxicity in the hippocampal cells. Beta amyloid (22-35) is a synthetic truncated fragment of beta-amyloid peptide. (In Vitro):β-Amyloid (22-35) shows significant cytotoxicity on the rat hippocampal neurons at 40 μg/mL, but exhibits no cytotoxic effect on the glial cells.
-
In Vitroβ-Amyloid 22-35 shows significant cytotoxicity on the rat hippocampal neurons at 40 μg/mL, but exhibits no cytotoxic effect on the glial cells.
-
In Vivo——
-
SynonymsAmyloid β-Protein (22-35)
-
PathwayMembrane Transporter/Ion Channel
-
TargetBeta Amyloid
-
RecptorAmyloid-β
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number144189-71-9
-
Formula Weight1403.62
-
Molecular FormulaC59H102N16O21S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 1.85 mg/mL (1.32 mMu)
-
SMILES——
-
Chemical NameSequence:Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Amyloid β-Protein 10...
Amyloid β-Protein (10-20) is a fragment of Amyloid-β peptide, maybe used in the research of neurological disease.Amyloid β protein fragment containing the α-secretase processing site (Lys16-Leu17 bond). It also contains the HHQK domain (residues 13-16) responsible for binding to microglial cells.
-
Aducanumab
Aducanumab (BIIB037), A selective human immunoglobulin gamma-1 (IgG1) monoclonal antibody, targets the clustered form of amyloid beta (Aβ). Aducanumab shows brain permeability and may be used to treat Alzheimer's disease (AD).
-
PPI-1019
PPI-1019 is an APP (β-amyloid A4) inhibitor for the treatment of neurological disorders and the study of Alzheimer's disease (AD).
Cart
sales@molnova.com